Cecilia Monge, M.D., M.P.H., FACP
Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer, colorectal cancer and pancreatic cancer.
1) gastrointestinal (GI) malignancies, 2) hepatocellular carcinoma, 3) biliary tract cancer,
4) colorectal cancer, 5) pancreatic cancer
Dr. Cecilia Monge is involved in clinical research focusing on novel first-in-human and early-phase clinical trials within the realm of gastrointestinal (GI) tumors and immunology. She has served as chair and investigator of multiple early stage clinical protocols within the National Cancer Institute, National Institutes of Health.
Selected Key Publications
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update.Nat Rev Clin Oncol. Epub ahead of print, 2019. [ Journal Article ]
Role of HSP90 Inhibitors in the Treatment of Cancer.In: Heat Shock Protein 90 in Human Diseases and Disorders. (Asea AA, Kaur P, eds.). Vol. 19: Springer 125-143, 2019. [ Book Chapter ]
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer.Clin Colorectal Cancer. Epub ahead of print (Jul 2), 2019. [ Journal Article ]
Patients with end-stage renal disease and acute myocard infarction have poor short-term outcomes despite modern cardiac intensive care.Coron Artery Dis. 19(4): 231-5, 2008. [ Journal Article ]
Dr. Cecilia Monge joined the Thoracic and GI Malignancies Branch as Staff Oncology Physician in 2019 after finishing her oncology fellowship with an outstanding academic award at the National Institutes of Health (NIH). She holds a Masters degree in public health from the Johns Hopkins University, Bloomberg School of Public Health and was selected to participate in the Global Clinical Scholars Research Training Program at Harvard Medical School. Dr. Monge completed her internal medicine training at Georgetown University after graduating from the Universidad de Costa Rica Medical School.
Dr. Cecilia Monge is the recipient of multiple national and international academic and research awards in oncology and internal medicine. She serves as a reviewer for various oncology academic journals and is a member of the American Academy of Cardiology (ACC) Cardio-Oncology Guidelines Writing Committee and the American Society of Clinical Oncology (ASCO) Trainee Council. Dr. Monge also serves on the NIH National Cancer Institute Institutional Scientific Review Board (IRB) for Clinical Studies and she is a fellow of the American College of Physicians.